How to Use the Newest Diabetes Treatment: Update 2017

Rancho Mirage, CA US
May 18, 2017

Michael Bush, MD
Clinical Chief, Division of Endocrinology, Cedars-Sinai Medical Center
Associate Clinical Professor
David Geffen School of Medicine at UCLA
Los Angeles, California

Target Audience

This activity was developed for physicians including Eisenhower medical staff along with nurses and ancillary staff.

Learning Objectives

At the end of this presentation, participants should be better able to:

  • List three criteria useful for diagnosis diabetes
  • Define the difference between the two types of incretin-based medications, a DDP4 inhibitor and a GLP1-Receptor Agonist
  • State the mechanism of action of an SGLT2 Inhibitor 
Course summary
Available credit: 
  • 1.00 AAFP
  • 1.00 AMA PRA Category 1 Credit(s)™
  • 1.00 Attendance
  • 1.00 APA
  • 1.00 CA-BRN
Course opens: 
05/18/2017
Course expires: 
12/31/2017
Event starts: 
05/18/2017 - 12:00pm
Event ends: 
05/18/2017 - 1:00pm
Cost:
$0.00
Rating: 
0
Annenberg Center for Health Sciences at Eisenhower
39000 Bob Hope Drive
Rancho Mirage, CA 92270
United States

Available Credit

  • 1.00 AAFP
  • 1.00 AMA PRA Category 1 Credit(s)™
  • 1.00 Attendance
  • 1.00 APA
  • 1.00 CA-BRN

Price

Cost:
$0.00
Please login or register to take this course.